Results 141 to 150 of about 149,963 (343)
Does Early Laser Treatment of Capillary Malformations Lead to More Favorable Outcomes?
The Laryngoscope, EarlyView.
Larkin Harris, Reema Padia
wiley +1 more source
Abstract Background Clinical outcome assessments (COAs) are essential for evaluating symptom severity, treatment response, and disease progression in Parkinson's disease (PD). As clinical knowledge evolves, it is necessary to revisit the recommendation status on the COAs to ensure their continued relevance and validity. Objectives To provide an updated
Evita Papathoma +14 more
wiley +1 more source
Clinical and Radiological Evolution of Idiopathic Normal Pressure Hydrocephalus: A Critical Review
Abstract Background The pathophysiology of idiopathic normal pressure hydrocephalus (iNPH) remains poorly understood. While it is commonly accepted that iNPH has an insidious onset, little is known about its preclinical and early stages and its development over time.
David Campo‐Caballero +6 more
wiley +1 more source
Loss‐of‐Function Variants in CPT1C: No Support for a Causal Role in Hereditary Spastic Paraplegia
Abstract Background Hereditary spastic paraplegias (HSPs) are neurodegenerative disorders characterized by lower‐limb spasticity. Pathogenic variants in CPT1C have been implicated in HSP. Objective The objective of this study was to assess whether CPT1C loss‐of‐function (LOF) variants are causally associated with HSP.
Rui Zhu +17 more
wiley +1 more source
Sleep disorders and their clinical significance in children with Down syndrome [PDF]
Stores, G., Stores, Rebecca
core +1 more source
Is surgery effective for reducing symptoms in adults with obstructive sleep apnea? [PDF]
Current evidence is insufficient to recommend surgery for symptom relief for patients with obstructive sleep apnea. More convincing evidence exists supporting the use of Continuous Positive Airway Pressure (CPAP) or dental appliances for reducing ...
Smith, Peter C.
core
Sleep apnea syndromes: impact of sleep and sleep states.
C. Guilleminault
semanticscholar +1 more source
Four doses of VK2735 and a placebo group were included in the VENTURE study. Adults who were overweight or had obesity had significant weight loss when taking any dose of VK2735 for 13 weeks. More people lost at least 10% of their body weight as the dose increased.
Harold E. Bays +9 more
wiley +1 more source
Prevalence, Severity, and Prognostic Value of Sleep Apnea Syndromes in Cardiac Amyloidosis. [PDF]
Bodez D +12 more
europepmc +1 more source

